Can You Ever Stop Taking Gout Medication? What the Largest Study Just Revealed

The Question Every Gout Doctor Hears Most

“Doc, my uric acid is normal now. Can I stop the pills?”

If you have gout and you are taking allopurinol or febuxostat, you have probably asked this. Maybe more than once. It is the single most common question rheumatologists hear, and until recently, they did not have great data to answer it.

The standard advice has long been: keep taking your medication, probably for life. But that answer rarely felt satisfying. Taking a pill every single day for decades is a lot. People worry about side effects, cost, and whether they are “dependent” on medication.

Now, for the first time, a large clinical trial has tested what actually happens when people with gout try to stop their urate-lowering therapy. The results were presented at the EULAR 2026 Congress in London, and they give us a real answer. Not a guess. Not a guideline recommendation based on expert opinion. Actual data from 309 real people.

What the GO TEST Finale Study Actually Found

Researchers in the Netherlands ran a randomized trial across nine rheumatology clinics. They took 309 people with gout who had achieved remission, meaning their uric acid was at target and they had not had a flare in a while. Then they split them into two groups.

One group kept taking their urate-lowering medication under a treat-to-target approach. The other group tried to stop.

After 24 months of follow-up, the results were clear:

• 79.2% of people who kept taking their medication stayed in remission, compared to 62.9% of those who tried to stop.
• The cumulative flare rate was 12.3% in the continuation group versus 31.8% in the discontinuation group. That is nearly three times more flares for people who stopped.
• 23% of people who tried to stop ended up restarting their medication, after a median of about 13 months.
• People who stopped needed more anti-inflammatory medication to manage flares.
• There was a modest kidney function benefit for those who stayed on treatment.

Here is the nuance, though. A significant chunk of people who stopped, about 63%, did stay in remission. This is not a situation where stopping means you will fail. But the odds are clearly worse.

The researcher who presented the findings, Iris Rose Peeters from Sint Maartenskliniek in the Netherlands, put it this way: the results support continuing medication at the population level, but they also provide real data for shared decision-making between doctors and individual people with gout.

Why Stopping Backfires for Most People

To understand why stopping medication leads to more flares, you need to understand what urate-lowering drugs actually do.

Allopurinol and febuxostat do not eliminate gout. They lower the amount of uric acid in your blood. When your uric acid stays below 6 mg/dL (or below 5 mg/dL if you have tophi), the crystals that have built up in your joints slowly start to dissolve. Think of it like salt dissolving in warm water. It takes time.

If you stop the medication, your uric acid climbs back up. The crystals that were dissolving stop dissolving. New ones start forming. And the ones that were halfway dissolved become unstable, which can actually trigger a flare.

This is why doctors talk about “crystal burden.” If you have had gout for years, you likely have a lot of urate crystals deposited in your joints and soft tissues, even if you cannot see or feel them. Lowering uric acid is about shrinking that load. Stopping the medication lets it grow back.

A large primary care study published in July 2026 drives this point home. Looking at 94,759 people with gout over 12 years, researchers found that only about 13% maintained good long-term uric acid control. People who started medication early, took higher doses when needed, and stuck with treatment did better. Those who delayed, quit early, or did not start at all did significantly worse.

The 4 Conditions That Need to Be Met Before Even Thinking About Stopping

The GO TEST study did not just tell people to stop cold turkey. There was a structured protocol. Based on the study design and clinical guidelines from EULAR and the American College of Rheumatology, here are the conditions that generally need to be met before anyone with gout should consider tapering medication:

1. Your uric acid has been at target for at least 6 to 12 months. Not just one good blood test. Sustained control. For most people, that means below 6 mg/dL. If you have tophi or frequent flares, below 5 mg/dL.

2. No flares in the past year. If you had a gout attack recently, your disease is not stable enough to risk stopping.

3. No visible tophi, and ideally imaging confirms crystals have dissolved. Ultrasound or dual-energy CT can show whether urate deposits are still in your joints. If they are, stopping is risky.

4. Your lifestyle factors are under control. Weight, diet, alcohol intake, and hydration all matter. If your lifestyle is a mess and medication is the only thing keeping your uric acid down, stopping will not go well.

Even when all four conditions are met, stopping should be a gradual taper, not an abrupt halt. Reduce the dose, monitor uric acid every few weeks, and be prepared to go back up if numbers creep up.

What Happens to Your Kidneys When You Stop

The GO TEST study found a modest kidney function benefit for people who stayed on urate-lowering therapy. This is not a minor detail.

Uric acid and kidney health are connected in both directions. Kidneys filter uric acid out of your blood. When kidney function declines, uric acid builds up. And when uric acid stays high, it can damage kidney tissue over time.

A separate article on this site covers the gout-kidney connection in detail. The short version: stopping medication that controls your uric acid does not just risk your joints. It risks your kidneys too.

In June 2026, the National Kidney Foundation held a scientific workshop specifically about gout management in people with chronic kidney disease. Their key finding was that gout in CKD is widely underdiagnosed and undertreated, and that the misconception of gout as a “lifestyle disease” prevents people from getting proper medication.

The Real Problem: Most People Quit Too Early, Not Too Late

Here is something that might surprise you. The biggest issue in gout treatment is not people who want to stop after years of good control. It is people who do not start, or who quit within the first few months.

That primary care study of 94,759 people found that 37% of people diagnosed with gout did not receive any urate-lowering medication at all. Among those who did start, the median duration of treatment was about 115 days. Less than four months.

Think about that. The GO TEST study followed people for 24 months. Most people in the real world quit before they even get close to that mark.

Adherence data from multiple studies puts real-world medication-taking rates at around 47%. That means more than half of people prescribed allopurinol or febuxostat are not taking it reliably.

This matters because the benefits of urate-lowering therapy build over time. The first few months can actually be rougher, because rapidly lowering uric acid can mobilize crystals and trigger flares. Doctors often prescribe colchicine or NSAIDs during this period to prevent that. But if you quit during the hard part, you do not get to the good part.

If you are struggling with flares after starting medication, understanding why pain can persist even when numbers look normal might help you push through.

What About Switching Medications Instead of Stopping?

Sometimes the issue is not the concept of taking medication, but the specific medication you are on. If allopurinol is causing side effects, switching to febuxostat (or vice versa) might be a better move than stopping entirely.

The 2020 ACR guidelines strongly recommend allopurinol as the first-choice medication for most people with gout, including those with mild to moderate kidney disease. But if you cannot tolerate it, febuxostat is an alternative. And if neither works well enough, there are other options like probenecid or, for severe cases, pegloticase.

The point is, “this pill does not agree with me” is a reason to talk to your doctor about switching, not a reason to give up on treatment altogether.

You can read more about how allopurinol and febuxostat compare to understand your options.

Questions to Ask Your Doctor

If you are thinking about stopping or reducing your gout medication, here is what to bring up at your next appointment:

• “How long has my uric acid been at target?” If the answer is less than 6 months, it is too early.
• “Do I still have urate deposits in my joints?” Imaging can answer this.
• “What is my kidney function, and would stopping affect it?”
• “If I want to try reducing my dose, what is the safest way to do it?”
• “What warning signs should I watch for if I do try tapering?”

The GO TEST study gives doctors better data to have this conversation. It is not a blanket “do not stop” or an irresponsible “go ahead and stop.” It is real numbers you can use to make an informed choice.

The Bottom Line

Can you ever stop taking gout medication? Sometimes, yes. About 63% of people who tried in the GO TEST study stayed in remission for two years without medication. But 31.8% had flares, 23% ended up back on medication, and those who continued had fewer flares and slightly better kidney function.

The safest approach is to get your uric acid to target, keep it there for at least a year with no flares, confirm that crystals have dissolved, and then talk to your doctor about a gradual taper. Monitor closely. Be ready to go back on if things change.

And if you are one of the many people who quit medication within the first few months, consider giving it another try. The first few months are the hardest. It gets better.

Frequently Asked Questions

How long do I need to take gout medication before I can consider stopping?

Based on clinical guidelines and the GO TEST study, you should have stable uric acid at target (below 6 mg/dL, or below 5 mg/dL with tophi) for at least 6 to 12 months, with no flares during that period. Most experts recommend at least a year of sustained control before even discussing a taper.

What happens if I stop taking allopurinol suddenly?

Your uric acid will likely rise within days to weeks. Crystals that were dissolving will stop, and new ones may form. This can trigger a gout flare. In the GO TEST study, people who stopped had nearly three times the flare rate of those who continued. Stopping should be a gradual taper under medical supervision, not an abrupt halt.

Can lifestyle changes replace gout medication?

Diet and lifestyle help, but they rarely lower uric acid enough on their own, especially if you have had gout for years or have high crystal burden. A study from the UK Biobank presented at EULAR 2026 showed that visceral fat and liver fat are strongly linked to gout risk, so weight management matters. But for most people with established gout, medication plus lifestyle changes works better than lifestyle alone.

Does stopping gout medication affect my kidneys?

Possibly. The GO TEST study found a modest kidney function benefit for people who stayed on urate-lowering therapy. High uric acid can damage kidney tissue over time, so letting it climb back up by stopping medication could have downstream effects on kidney health. If you have chronic kidney disease, this is an especially important consideration.

If I stop and restart medication, will it still work?

Generally yes. Urate-lowering medications like allopurinol and febuxostat work the same way whether you are starting for the first time or restarting after a break. However, restarting means going through the adjustment period again, including the risk of mobilization flares during the first few months. You may also need prophylactic anti-inflammatory medication during this time.

Are there any new medications that might let me stop taking pills?

Research is ongoing. At EULAR 2026, a new formulation called HR091506 (an extended-release version of febuxostat) showed better uric acid control in a Phase 3 trial. But newer or stronger medications do not mean you can stop sooner. The goal is still sustained crystal dissolution, which takes time regardless of which drug you use.

Reviewed by the GoutSavvy Editorial Team